• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday

    7/8/24 10:19:23 AM ET
    $ABSI
    $FLNC
    $GLW
    $GRFS
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ABSI alert in real time by email

    U.S. stocks were higher, with the Dow Jones index surging around 200 points on Monday.

    Shares of Corning Incorporated (NYSE:GLW) rose sharply during Monday's session after the company increased its second-quarter core sales guidance.

    The company said it now projects core sales to be approximately $3.6 billion (vs. consensus of $3.41 billion), an increase from the previous guidance of $3.4 billion. Core EPS is expected to reach the high end of, or slightly exceed, the management's guided range of $0.42 to $0.46 (vs. estimate of $0.45).

    Corning shares jumped 9.4% to $42.05 on Monday.

    Here are some other big stocks recording gains in today’s session.

    • Morphic Holding, Inc. (NASDAQ:MORF) shares gained 75% to $55.72 after Eli Lilly agreed to buy the company for $57 per share in cash.
    • Nikola Corporation (NASDAQ:NKLA) shares climbed 18.5% to $10.65.
    • Grifols, S.A. (NASDAQ:GRFS) rose 17.2% to $8.24 after Brookfield confirmed it held exploratory discussions with certain shareholders of the company in relation to a potential joint offer for Grifols’ shares.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) jumped 17.2% to $14.13 after the company announced it received the Breakthrough Device Designation from the FDA for its Cardiac Surgery System for the ablation of cardiac tissue for the treatment of atrial fibrillation.
    • Newegg Commerce, Inc. (NASDAQ:NEGG) gained 16% to $1.23. Newegg Commerce said the Presale for its tenth annual FantasTech Sales event is now live.
    • NANO Nuclear Energy Inc. (NASDAQ:NNE) shares rose 12.3% to $31.89 after surging 20% on Friday.
    • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shares climbed 12.1% to $38.41 after the company announced interim Phase 2 monotherapy expansion data for IDE397 in MTAP-deletion urothelial and lung cancer. Additionally, Mizuho initiated coverage on the stock with an Outperform rating.
    • Absci Corporation (NASDAQ:ABSI) rose 12% to $3.55.
    • SolarEdge Technologies, Inc. (NASDAQ:SEDG) gained 11.3% to $27.88 after B of A Securities upgraded the stock from Underperform to Neutral.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) rose 11% to $1.08.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) gained 6.5% to $902.31.
    • Fluence Energy, Inc. (NASDAQ:FLNC) gained 6.2% to $17.61.
    • Lucid Group, Inc. (NASDAQ:LCID) climbed 4.7% to $3.06 after the company reported second-quarter production and deliveries.
    • Tandem Diabetes Care, Inc. (NASDAQ:TNDM) rose 4.7% to $42.33.
    • Paramount Global (NASDAQ:PARAA) climbed 4.6% to $21.41. Paramount Global and Skydance Media inked a definitive agreement to create a new entity, "New Paramount," in a $28 billion merger deal.
    • Intel Corporation (NASDAQ:INTC) rose 3.8% to $33.26. Intel has bypassed Vietnam for a substantial investment project, citing insufficient investment incentives.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 3.8% to $15.35.

    Now Read This: Wall Street’s Most Accurate Analysts Say Buy These 3 Utilities Stocks Delivering High-Dividend Yields

    Get the next $ABSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABSI
    $FLNC
    $GLW
    $GRFS

    CompanyDatePrice TargetRatingAnalyst
    Tandem Diabetes Care Inc.
    $TNDM
    2/23/2026$50.00Hold → Buy
    Lake Street
    Tandem Diabetes Care Inc.
    $TNDM
    2/20/2026$30.00Underperform → Neutral
    BofA Securities
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    SolarEdge Technologies Inc.
    $SEDG
    2/19/2026$38.00 → $43.00Buy
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    More analyst ratings

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Director Van Houten Frans bought $148,800 worth of shares (40,000 units at $3.72), increasing direct ownership by 172% to 63,320 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    12/9/25 4:04:20 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Pangalos Menelas N bought $254,788 worth of shares (95,785 units at $2.66), increasing direct ownership by 527% to 113,960 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    9/24/25 4:03:44 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mcclain Sean exercised 396,399 shares at a strike of $1.21 and covered exercise/tax liability with 267,008 shares, increasing direct ownership by 2% to 8,463,958 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    2/25/26 6:05:16 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Chief Commercial Officer Danahy Kevin Patrick exercised 5,000 shares at a strike of $1.53 and sold $118,200 worth of shares (5,000 units at $23.64) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/23/26 8:55:39 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Accounting Officer Philpot Michelle

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    2/20/26 4:09:01 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $ABSI
    $FLNC
    $GLW
    $GRFS
    SEC Filings

    View All

    SEC Form 6-K filed by Grifols S.A.

    6-K - Grifols SA (0001438569) (Filer)

    2/26/26 4:25:07 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Grifols S.A.

    6-K - Grifols SA (0001438569) (Filer)

    2/26/26 2:48:42 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Rivian Automotive Inc.

    144 - Rivian Automotive, Inc. / DE (0001874178) (Subject)

    2/25/26 5:05:01 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tandem Diabetes Care upgraded by Lake Street with a new price target

    Lake Street upgraded Tandem Diabetes Care from Hold to Buy and set a new price target of $50.00

    2/23/26 8:30:19 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Tandem Diabetes Care upgraded by BofA Securities with a new price target

    BofA Securities upgraded Tandem Diabetes Care from Underperform to Neutral and set a new price target of $30.00

    2/20/26 8:21:03 AM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    Polestar Automotive Holding UK PLC downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Polestar Automotive Holding UK PLC from Neutral to Underweight

    2/19/26 7:50:28 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Supermicro Introduces Industry's Highest Density AMD EPYC™ 4005 Series MicroBlade® for Cloud, Edge, and SaaS Workloads

    Delivers Unmatched Scalability, Flexibility, Energy EfficiencyOptimized for specialized compute including e-commerce and cybersecurityUp to 40 server nodes in a 6U enclosureSAN JOSE, Calif., Feb. 26, 2026 /PRNewswire/ -- Supermicro, Inc. (NASDAQ:SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, is announcing the launch of the industry's first and highest-density blade server platform powered by the latest AMD EPYC™ 4005 series processors. Designed with a flexible, density-optimized blade architecture, Supermicro's new MicroBlade platform is designed for longevity and versatility. By including the latest AMD EPYC 4005 series processors, along with previous versions, the

    2/26/26 9:05:00 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    Supermicro and VAST Data Launch a New Enterprise AI Data Platform Solution with NVIDIA to Accelerate AI Factory Deployment

    Platform brings high-performance compute, scalable data infrastructure, and intelligent software together as one ready-to-run solution.Fully integrated AI infrastructure stack includes Supermicro compute and storage servers, VAST AI OS, and NVIDIA accelerated computing models and software.SAN JOSE, Calif. and SALT LAKE CITY, Feb. 25, 2026 /PRNewswire/ -- VAST Forward -- Supermicro, Inc. (NASDAQ:SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, is launching, with VAST Data, the CNode-X Solution, a highly integrated, rapidly deployable AI Data Platform. The VAST AI Operating System, including the VAST InsightEngine and VAST DataBase, together with NVIDIA open models, mic

    2/25/26 1:35:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    CPower, Bentaus and Supermicro Successfully Flex AI Compute Load for Demand Response

    Joint test proves GPU-based workloads can be real-time grid resources as power demand for AI surges tenfoldBALTIMORE and DALLAS and SAN JOSE, Calif., Feb. 25, 2026 /PRNewswire/ -- CPower Energy ("CPower"), a leading Virtual Power Plant (VPP) platform, and Bentaus, a leading developer of AI-driven energy orchestration platforms, in collaboration with Supermicro (NASDAQ:SMCI), a global leader in Application-Optimized Total IT Solutions, today announced the successful completion of a joint demonstration of how AI compute infrastructure can provide fast, reliable flexibility to the electric grid. In the test, CPower dispatched real-time wholesale electricity market signals from California Indepe

    2/25/26 9:01:00 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    $ABSI
    $FLNC
    $GLW
    $GRFS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    November 7, 2023 - FDA Roundup: November 7, 2023

    For Immediate Release: November 07, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA issued a Safety Communication warning consumers, health care providers, and health care facilities not to use recalled saline (0.9% sodium chloride) and sterile water medical products manufactured by Nurse Assist, LLC. On November 6, Nurse

    11/7/23 3:38:18 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Leadership Updates

    Live Leadership Updates

    View All

    IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer

    SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D and Site Head for the Bay Area. 

    2/23/26 6:00:00 AM ET
    $IDYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NANO Nuclear Expands its Nuclear Policy Leadership Expertise with the Appointment of U.S. Government Veteran Sarah Lennon as its International Nuclear Policy Advisor

    New York, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced the appointment of Sarah Lennon as its International Nuclear Policy Advisor. Sarah is a seasoned national security and nuclear energy policy leader with three decades of distinguished service across the U.S. Government, bringing deep expertise in nuclear security, nonproliferation, international cooperation, and strategic planning. "It is a pleasure to join the NANO Nuclear team," said Sarah Lennon, International Nuclear Policy A

    2/20/26 8:30:00 AM ET
    $NNE
    Electric Utilities: Central
    Utilities

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Newegg Commerce Inc.

    SC 13D/A - Newegg Commerce, Inc. (0001474627) (Subject)

    12/17/24 4:37:51 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Paramount Global

    SC 13D/A - Paramount Global (0000813828) (Subject)

    12/12/24 4:14:51 PM ET
    $PARAA
    Broadcasting
    Industrials

    Amendment: SEC Form SC 13G/A filed by Corning Incorporated

    SC 13G/A - CORNING INC /NY (0000024741) (Subject)

    11/22/24 6:06:27 AM ET
    $GLW
    Telecommunications Equipment
    Industrials

    $ABSI
    $FLNC
    $GLW
    $GRFS
    Financials

    Live finance-specific insights

    View All

    Lucid Announces Fourth Quarter and Full Year 2025 Financial Results

    Financial HighlightsDelivered 5,345 vehicles in Q4 and 15,841 vehicles in 2025; up 72% compared to Q4 2024 and up 55% compared to full year 2024Nearly doubled production year over year and in-line with 2025 annual production guidance of approximately 18,000 vehicles despite supply chain and tariff headwindsQ4 2025 revenue of $522.7 million, up 123% compared to Q4 2024, and annual revenue of $1,353.8 million, up 68% compared to full year 2024GAAP diluted net loss per share of $(3.62) in Q4 2025 and $(12.09) in full year 2025Ended the quarter with approximately $4.6 billion in total liquidity2026 production guidance of 25,000-27,000 vehiclesOperational HighlightsAchieved an eighth consecutive

    2/24/26 4:05:00 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

    VANCOUVER, Wash. and NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2025 after market close on Tuesday, March 24, 2026. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company's investor relations website at: investors

    2/24/26 8:00:00 AM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance

    Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026. Fourth Quarter 2025 Financial and Strategic Highlights Achieved record quarterly sales: Worldwide sales of $290.4 million United States sales of $210.5 million Worldwide pump shipments of 38,000 United States pump shipments of 27,000 Delivered meaningful operational improvement: Record quarterly gross margin of 58% Operating income of $8.3 million, or 3% of sales Net loss of $0.6 million with posi

    2/19/26 4:05:00 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care